Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia

BACKGROUND: Drug coverage policies that incentivize switching patients from originator to biosimilar products may result in significant health care savings. Our study aimed to detect early impacts on health services utilization following a mandated switch from originator to biosimilar etanercept in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Anat, Kim, Jason D., Carney, Greg, Dormuth, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793256/
https://www.ncbi.nlm.nih.gov/pubmed/35081991
http://dx.doi.org/10.1186/s41927-021-00235-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793256/
https://www.ncbi.nlm.nih.gov/pubmed/35081991
http://dx.doi.org/10.1186/s41927-021-00235-x

Ejemplares similares